BSc – Trinity College, University of Toronto, Canada (2000)
MD – University of Toronto, Canada (2004)
MPH – Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (2010)
- Pediatric hematology-oncology in resource-limited settings: evaluating outcomes, applying quality improvement efforts and implementing best practices
- Improving patient outcomes by addressing timely diagnosis, treatment abandonment and palliative care needs
- Advancing outcomes in rare solid tumors, including adrenocortical tumors and nasopharyngeal carcinoma
- Health disparities research; health literacy and patient education
- Optimizing treatment and research for children, adolescents and young adults with solid tumors
Weaver MS, Yao AJ, Renner LA, Harif M, Lam CG. The prioritisation of paediatrics and palliative care in cancer control plans in Africa. Br J Cancer 112(12):1845-56, 2015. doi: 10.1038/bjc.2015.158.
Salaverria C, Rossell N, Hernandez A, Fuentes Alabi S, Vasquez R, Bonilla M, Lam CG, Ribeiro RC. Interventions targeting absences increase adherence and reduce abandonment of childhood cancer treatment in El Salvador. Pediatr Blood Cancer. Epub ahead of print April 29, 2015. doi: 10.1002/pbc.25557.
Vern-Gross TZ, Lam CG, Graff Z, Singhal S, Levine DR, Gibson D, Coan A, Anghelescu DL, Yuan Y, Baker JN. Patterns of End-of-Life Care in Children with Advanced Solid Tumor Malignancies Enrolled on a Palliative Care Service. J Pain Symptom Manage Apr 16, 2015. Epub ahead of print. pii:S0885-3924(15)00171-2. doi:10.1016/j.jpainsymman.2015.03.008.
Ceppi F, Antillon F, Pacheco C, Sullivan CE, Lam CG, Howard SC, Conter V. Supportive medical care for children with acute lymphoblastic leukemia in low- and middle-income countries. Expert Rev Hematol 26:1-14, 2015.
Parikh NS, Howard SC, Chantada G, Israels T, Khattab M, Alcasabas P, Lam CG, Faulkner L, Park JR, London WB, Matthay KK. SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settings. Pediatr Blood Cancer 62(8):1305-16, 2015. doi:10.1002/pbc.25501.
Weaver MS, Howard SC, Lam CG. Defining and Distinguishing Treatment Abandonment in Patients With Cancer. J Pediatr Hematol Oncol 37(4):252-6, 2015. doi:10.1097/MPH.0000000000000319.
Weaver MS, Arora RS, Howard SC, Salaverria CE, Liu YL, Ribeiro RC, Lam CG. A practical approach to reporting treatment abandonment in pediatric chronic conditions. Pediatr Blood Cancer 62(4):565-70, 2015. doi:10.1002/pbc.25403.
Caruso Brown AE, Howard SC, Baker JN, Ribeiro RC, Lam CG. Reported Availability and Gaps of Pediatric Palliative Care in Low- and Middle-Income Countries: A Systematic Review of Published Data. J Palliat Med 17(12):1369-1383, 2014.
Weaver MS, Heminger CL, Lam CG. Integrating stages of change models to cast new vision on interventions to improve global retinoblastoma and childhood cancer outcomes. BMC Public Health 14(1):944, 2014.
Lam CG, Furman WL, Wang C, Spunt SL, Wu J, Ivy P, Santana VM, McGregor LM. Phase I clinical trial of ifosfamide, oxaliplatin, and etoposide (IOE) in pediatric patients with refractory solid tumors. J Pediatr Hematol Oncol 37(1):e13-8, 2014.
Weaver MS, Lam CG. Improving retinoblastoma outcomes through a stage-based intervention model. Lancet Glob Health 2(3):E143, 2014.
Levine D, Lam CG, Cunningham MJ, Remke S, Chrastek J, Klick J, Macauley R, Baker JN. Best practices for pediatric palliative cancer care: a primer for clinical providers. J Support Oncol 11(3):114-25, 2013.
Lam CG, Cohen KJ, Roter DL. Coping Needs in Adolescents with Cancer: A Participatory Study. J Adolesc Young Adult Oncol 2(1):10-16, 2013.
Gupta S, Yeh S, Martiniuk A, Lam CG, Chen HY, Liu YL, Tsimicalis A, Arora RS, Ribeiro RC. The magnitude and predictors of abandonment of therapy in paediatric acute leukaemia in middle-income countries: A systematic review and meta-analysis. Eur J Cancer 2013 Apr 15. doi:pii: S0959-8049(13)00258-X. 10.1016/j.ejca.2013.03.024.
Lam CG, Roter DL, Cohen KJ. Survey of Quality, Readability, and Social Reach of Websites on Osteosarcoma in Adolescents. Patient Educ Couns 90(1):82-87, 2013. First published Sep 4, 2012. doi:10.1016/j.pec.2012.08.006.
Lam CG, Rossell N, Ribeiro RC. Global Snapshots of Treatment Abandonment in Children and Adolescents with Cancer: Social Factors, Implications, and Priorities. J Healthcare, Science and Humanities 2(1):81-110, 2012.
Lam CG, Manlhiot C, Pullenayegum EM, Feldman BM. Efficacy of intravenous Ig therapy in juvenile dermatomyositis. Ann Rheum Dis 70(12):2089-2094, 2011.
Mostert S, Arora RS, Arreola M, Bagai P, Friedrich P, Gupta S, Kaur G, Koodiyedath B, Kulkarni K,Lam C, Luna-Fineman S, Pizer B, Rivas S, Rossell N, Sitaresmi MN, Tsimicalis A, Weaver M, Ribeiro RC. Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group. Lancet Oncol 12(8):719-20, 2011.
Lam C, Bouffet E, Tabori U, Mabbott D, Taylor M, Bartels U. Rapamycin (Sirolimus) in Tuberous Sclerosis Associated Pediatric Central Nervous System Tumors, Pediatric Blood & Cancer 54(3):476-9, 2010.
Lam C, Bouffet E, Bartels U. Nimotuzumab in Pediatric Glioma. Future Oncology 5(9):1349-1361, 2009.
Porepa M, Lam C, Huber J, Au H, Birken C. Kids on Kids’ Health: Creating a Child Health Magazine with Students from an Urban, Multicultural, Low Income Elementary School. Paediatrics & Child Health 14(4):219-221, 2009.
Dipchand A, Friedman J, Bismilla Z, Gupta S, Lam C. The Hospital for Sick Children Handbook of Pediatrics, 11th Edition, Elsevier Sciences, 2009.
Pullenayegum EM, Lam C, Manlhiot C, Feldman BM. Fitting marginal structural models: estimating covariate-treatment associations in the reweighted data set can guide model fitting. J Clin Epidemiol 61(9):875-81, 2008.
Lam C, Tjon J, Hamilton J, Ahmet A. Recurrent anaphylaxis associated with gonadotropin-releasing hormone analogs: case report and review of the literature. Pharmacotherapy 26(12):1811-5, 2006.
Lam C, Young N, Marwaha J, McLimont M, Feldman BM. Revised versions of the Childhood Health Assessment Questionnaire (CHAQ) are more sensitive and suffer less from a ceiling effect. Arthritis & Rheumatism 51(6):881-9, 2004.
Lam C, Badiwala M, Froeschl M. Morning Report: Truth serum. Univ Tor Med J 79(2):136-141, 2002.
Cowan KN, Heilbut A, Humpl T, Lam C, Ito S, Rabinovitch M. Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nature Medicine Jun;6(6):698-702, 2000.
Last update: July 2015